Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.

Wu, Q-Y; Yuan, F-L; Wang, B; Li, X

Wu, Q-Y; Yuan, F-L; Wang, B; Li, X.

Afiliação

Wu QY; Department of Orthopaedics and Central Laboratory, The Third Hospital Affiliated to Nantong University, Wuxi, 214041, Jiangsu, China.
Yuan FL; Department of Orthopaedics and Central Laboratory, The Third Hospital Affiliated to Nantong University, Wuxi, 214041, Jiangsu, China.
Wang B; Department of Orthopaedics and Central Laboratory, The Third Hospital Affiliated to Nantong University, Wuxi, 214041, Jiangsu, China.
Li X; Department of Orthopaedics and Central Laboratory, The Third Hospital Affiliated to Nantong University, Wuxi, 214041, Jiangsu, China. lixia.ahmu.cn@163.com.

Osteoporos Int ; 29(9): 2157, 2018 09.

Article em En | MEDLINE | ID: mdl-29978255

Assuntos

Conservadores da Densidade Óssea; Fraturas Ósseas; Difosfonatos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fraturas Ósseas / Conservadores da Densidade Óssea Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Osteoporos Int Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google